Advertisement

Serum pattern of parathyroid hormone, calcitonin and calcium following a calcium-rich test meal in patients with recurrent calcium urolithiasis and controls

  • P. O. Schwille
  • G. Rümenapf
  • A. Sigel
Conference paper
Part of the Fortschritte der Urologie und Nephrologie book series (2824, volume 25)

Abstract

The metabolism of calcium, parathyroid hormone (PTH) and calcitonin in recurrent idiopathic normo- and hypercalciuric urolithiasis (RCU) is at present far from being resolved. Among the reasons are lacking data on 1) the unclarified nature of intestinal calcium hyperabsorption in patients with idiopathic hypercalciuria (I-HC), 2) the dynamics of serum calcium in response to calcium fluxes into the blood in both normo- and hypercalciuric patients, 3) the dynamics of the associated PTH immunoreactivity, as well as on the suppressibility of the parathyroid glands, as reflected for example by cyclic AMP (cAMP) in urine, 4) the ability of oral calcium to stimulate calcitonin as a protective factor toward nephrocalcinosis (1), and as a potentially hypercalciuric agent (2).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Peng TC (1984) Protective effect of thyrocalcitonin against nephrocalcinosis induced by parathyroid hormone in rats. Mol Cell Endocrinol 2: 1–15CrossRefGoogle Scholar
  2. 2.
    Kestenbaum RS, Winikoff Y, Lismer PL (1984) The role of calcitonin in calcium stone formation. Nephron 38: 154–155CrossRefGoogle Scholar
  3. 3.
    Scholz D, Schwille PO (1981) Klinische Laboratoriumsdiagnostik der Urolithiasis. Dtsch Med Wochenschr 106: 999–1002PubMedCrossRefGoogle Scholar
  4. 4.
    Schwille PO (1979) Bestimmung von Parathormon im Serum — gegenwärtiger Stand. In: Domschke W, Koch H (eds) Diagnostik in der Gastroenterologie. Thieme, Stuttgart, pp 324–330Google Scholar
  5. 5.
    Dietrich FM, Hunziker WH, Fischer JA (1975) Synthetic human calcitonin. Analysis of antibodies obtained from various animal species and determination of immunoreactive hormone in human sera. Acta Endocrinol 80: 463–474Google Scholar
  6. 6.
    Schwille PO, Rümenapf G, Sigel A (1986) Pattern of serum parathyroid hormone (PTH), calcitonin (CT) and calcium following an oral calcium-rich test meal in renal calcium stone disease. Urol Res 14: 85 (abstr)Google Scholar
  7. 7.
    Liberman UA, Sperling 0, Alsmon A, Frank M, Modan M, de Vries A (1968) Metabolic and calcium kinetic studies in idiopathic hypercalciuria. J Clin Invest 47: 2580–2590Google Scholar
  8. 8.
    Bordier P, Ryckewart A, Gueris K, Rasmussen H (1977) On the pathogenesis of so-called idiopathic hypercalciuria. Am J Med 63: 398–409PubMedCrossRefGoogle Scholar
  9. 9.
    Messa P, Mioni G, Montamaro D, Adorati M, Antonucci F, Messa M, Enzmann G, Paganin L, Nardini R (1986) About a primitive osseous origin of the so-called “Renal Hypercalciuria”. Third Int Symp Urolith, Turin, March 21–22. (abstr)Google Scholar
  10. 10.
    Sutton RL (1986) Renal handling of calcium and magnesium in idiopathic calcium stone disease. Third Int Symp Urolith, Turin, March 21–22. (abstr)Google Scholar
  11. 11.
    Mallon JP, Matuszewski DS, Baggiolini EG, Partridge JJ, Uskokovic MR (1981) Effect of 1,25-dihydroxycholecalciferol analogs on bone resorption in vitro. J Steroid Biochem 14: 599–602PubMedCrossRefGoogle Scholar
  12. 12.
    Guthmann II HM, Palmieri GMA, Hinton AB, Guthmann AL (1982) The mechanism of insulin-induced hypercalcemia in the chick. Endocrinology 110: 571–574PubMedCrossRefGoogle Scholar
  13. 13.
    Katz JM, Skinner SJM, Wilson T, Gray DH (1983) The in vitro effect of indomethacin on basal bone resorption, on prostaglandin production and on the response to added prostaglandins. Prostaglandins 26: 545–556PubMedCrossRefGoogle Scholar
  14. 14.
    Rümenapf G, Schwille PO (1985) Plasma insulin and C-peptide in classified subgroups of calcium stone formers — influence of a test meal and relationship to urinary calcium and phosphate. Fortschr Urol Nephrol 23: 93–98Google Scholar
  15. 15.
    Insogna KL, Broadus AE, Dreyer BE, Ellison AF, Gertner JM (1985) Elevated production rate of 1,25-Dihydroxyvitamin D in patients with absorptive hypercalciuria. J Clin Endocrinol Metab 61: 490–495PubMedCrossRefGoogle Scholar
  16. 16.
    Arnaud CD, Zitzner LA (1983) Clinical utility of “Mid” and “Carboxyl” region specific assays of parathyroid hormone. In: Frame B, Potts JT (eds) Clinical disorders of bone and mineral metabolism. Excerpta Medica, Amsterdam Oxford Princeton, pp 10–19Google Scholar
  17. 17.
    Cohn DV, Elting JJ (1984) Synthesis and secretion of parathormone and secretory protein-I by the parathyroid gland. In: Peck WA (ed) Bone and Mineral Research, Annual 2. Elsevier, Amsterdam New York Oxford, pp 1–64Google Scholar
  18. 18.
    Evans RE, Hills E, Wong SYP, Wyndham LE, Eade Y, Dunstan CR (1984) The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction. Q J Med 209: 41–53Google Scholar
  19. 19.
    Shainkin-Kestenbaum R, Winikoff Y, Paran E, Lismer L (1984) The role of calcitonin in calcium stone formation. Nephron 38: 154–155PubMedCrossRefGoogle Scholar
  20. 20.
    Ivey JL, Roos BA, Shen FH, Baylink DJ (1981) Increased immunoreactive calcitonin in idiopathic hypercalciuria. Metab Bone Dis Relat Res 3: 39–42PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG., Darmstadt 1987

Authors and Affiliations

  • P. O. Schwille
    • 1
    • 2
  • G. Rümenapf
    • 1
  • A. Sigel
    • 1
  1. 1.Mineral Metabolism and Endocrine Research LaboratorySurgical and Urological University ClinicErlangenWest Germany
  2. 2.Chirurgische KlinikUniversitäts-KrankenhausErlangenWest Germany

Personalised recommendations